MT1-MMP has been shown to contribute to the aggressiveness of several cancers, including GBM.8 Here we sought to further characterize the importance of MT1-MMP in GBM to determine if targeting the protein might have clinical utility. This evidence concerns the gene MMP14 and glioblastoma.